Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar;25(3):299-305.
doi: 10.1016/j.jsps.2016.09.008. Epub 2016 Sep 30.

Pharmacovigilance system in Saudi Arabia

Thamir M Alshammari  1 , Mohammed Alshakka  2 , Hisham Aljadhey  3
Affiliations
Review

Pharmacovigilance system in Saudi Arabia

Thamir M Alshammari et al. Saudi Pharm J. 2017 Mar.

Abstract

Pharmacovigilance plays an important role in ensuring that patients are receiving safe drugs. In Saudi Arabia, Saudi Food and Drug Authority, health institutions, marketing authorization holders and healthcare professional are involved in pharmacovigilance activities regardless of the level of the involvement. Although pharmacovigilance is well established in developed nations and it is considered a new concept in Saudi Arabia. It is a collective effort from various stakeholders to make pharmacovigilance successful toward promoting safe and effective use of medicines among the population. However, the practice of pharmacovigilance still needs more attention especially from marketing authorization holders and healthcare professionals. The aim of this review was to describe the current situation of pharmacovigilance in Saudi Arabia and the activities that have been conducted by the stakeholders.

Keywords: ADRs; Drug safety; Healthcare system; Pharmacovigilance; Risk management plan.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Saudi Food and Drug Authority ADR-1 paper reporting form for healthcare professionals.
Figure 2
Figure 2
The online portal to the pharmacovigilance electronic reporting services.
See this image and copyright information in PMC

References

    1. Aljadhey H. Challenges to and the future of medication safety in Saudi Arabia: a qualitative study. Saudi Pharm. J. 2014;22(4):326–332. - PMC - PubMed
    1. Almalki M., Fitzgerald G., Clark M. Health care system in Saudi Arabia: an overview. East. Mediterr. Health J. 2011;17(10):784–793. - PubMed
    1. Alrwisan A.A. Community pharmacists’ knowledge of isotretinoin safety. Saudi Med. J. 2014;35(1):81–84. - PubMed
    1. Center, Uppsala Monitoring ’Uppsala Reports 45. The Uppsala Monitoring Center. <http://who-umc.org/graphics/24355.pdf> (accessed 27/03/2014)’.
    1. Chisholm-Burns M.A. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med. Care. 2010;48(10):923–933. - PubMed

LinkOut - more resources